Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

Lawsuit Challenges Trump’s $100,000 H‑1B Fee

by Team Lumida
October 4, 2025
in Macro
Reading Time: 4 mins read
A A
0
Trump Delays Reciprocal Tariffs to August 1, Citing Progress in Trade Negotiations
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

Powered by lumidawealth.com

  • A coalition led by healthcare‑staffing firm Global Nurse Force and several labor unions filed suit in the Northern District of California to block the administration’s new $100,000 fee on each new H‑1B petition.
  • Plaintiffs argue the President lacked authority to impose the fee unilaterally and that the rule violates the Administrative Procedure Act (arbitrary, capricious, and skipping required rulemaking).
  • The challenge is the first major legal test of the policy and arrives amid broader litigation over other administration actions; the suit targets new visas only, not renewals.
  • Large tech firms largely stayed out of the initial suit, while plaintiffs come from healthcare, education and religious sectors—underscoring cross‑sector disruption.
  • If upheld or partially enforced, the fee would dramatically raise hiring costs for employers relying on foreign skilled labor, with knock‑on effects for recruitment, project timing, wage dynamics and staffing‑sensitive industries.

What happened?

A healthcare‑staffing company and unions sued to enjoin the administration from implementing a sweeping $100,000 fee on new H‑1B petitions, arguing the President exceeded his statutory authority and failed to follow required notice‑and‑comment rulemaking. The complaint seeks to block the fee nationwide; plaintiffs cite constitutional “power of the purse” concerns and rely on the Administrative Procedure Act to challenge the policy’s legality.

Why it matters

The litigation creates immediate uncertainty for companies, universities and hospitals that use H‑1B visas to fill specialized roles: a legally enforced $100k fee per new hire would sharply increase labor costs, slow hiring, and incentivize firms to repatriate roles, accelerate automation, or shift offshore hiring strategies—each with implications for revenue, margins and project timelines in tech, healthcare staffing, research institutions and other talent‑intensive sectors. Even the prospect of the fee changes workforce planning and could push up wage offers for comparable domestic hires, complicating payroll forecasts and talent budgets. Politically and legally, a court victory for plaintiffs would block the administration’s shortcut around Congress and constrain future executive attempts to reshape immigration economics; a loss or narrow ruling could embolden further unilateral policy moves and widen litigation and compliance costs for employers.

What’s next

Expect rapid legal skirmishing and early injunctive motions—watch for a preliminary‑injunction decision that will determine whether the fee is enforced while the case proceeds; concurrently, monitor whether other plaintiffs (including big tech or trade groups) file suit or seek to join, and whether Congress responds with statutory action or appropriation riders. Companies should assess near‑term hiring pipelines for exposure to new‑hire petitions, model scenarios with and without the fee for budgeting and headcount planning, and track administrative guidance on implementation timing; firms dependent on H‑1B talent will also need contingency plans (expedited remote hiring, retention offers, role redesign) while the litigation and political debate play out.

Source
Previous Post

OpenAI Reverses Sora Copyright Stance

Next Post

China Pushes Trump to Ease Security Curbs in Exchange for Investment

Recommended For You

Trump in ‘Revenge Mode’ as Iran War Drags On — Threatens Power Plants, Surges Forces, as Iran Rebuilds Fast and Houthis Hit Saudi Tankers

by Team Lumida
2 days ago
Supreme Court Signals It Will Strike Down Trump’s Birthright Citizenship Order

President Trump has grown deeply impatient with the Iran war, entering what a senior official calls 'revenge mode' — threatening to bomb Iranian power plants and bridges, surging...

Read more

Houthis Open Second Maritime Front — Blockade Saudi Oil Through Bab al-Mandeb, Sending Brent Briefly to $100

by Team Lumida
2 days ago
Iran’s Island Fortress: The Five Strategic Positions Holding Hormuz Hostage

Yemen's Houthis have opened a second maritime chokepoint in the US-Iran war, declaring a blockade on Saudi oil shipments through the Bab al-Mandeb strait and attacking two Saudi...

Read more

Trump Unveils New 10-12.5% Tariffs on Major Trading Partners — Replacing Supreme Court-Struck Duties With Forced-Labor Justification

by Team Lumida
2 days ago
Supreme Court Signals It Will Strike Down Trump’s Birthright Citizenship Order

The Trump administration unveiled new tariffs of 10% to 12.5% on major trading partners, justified on forced-labor grounds, to replace the temporary 10% global tariff expiring Friday —...

Read more

Brent Crude Tops $100 for First Time Since May — US Oil Surges 6.2% as Iran War Drives Treasury Yields to Trump-Era Highs and Stocks Slump

by Team Lumida
2 days ago
birds eye photography of concrete structure

Brent crude cracked $100/barrel for the first time since May as Trump threatened 'major military punishment' against Iran over Houthi attacks on Saudi tankers — sending US oil...

Read more

Iran War Drives 10-Year Treasury Yield to 4.665% — Near 2026 High — as Bond Market Prices Persistent Inflation Risk

by Team Lumida
4 days ago
close-up photo of monitor displaying graph

The 10-year US Treasury yield hit 4.665% — just below its 2026 intraday high of 4.687% set in May — as the Iran war drives a sustained bond...

Read more

Singapore Core Inflation Rises to 1.6% as Iran War Energy Costs Filter Through — MAS Meeting Monday a Close Call

by Team Lumida
4 days ago
landscape photography of Sydney, Australia

Singapore's core inflation accelerated to 1.6% in June from 1.4% in May as higher global energy costs from the Iran war begin passing through supply chains, with electricity...

Read more

Trump Approves Landmark 30-Year Nuclear Deal With Saudi Arabia — Opening Door to Uranium Enrichment and Raising Proliferation Alarm

by Team Lumida
5 days ago
Supreme Court Signals It Will Strike Down Trump’s Birthright Citizenship Order

President Trump has formally approved a landmark 30-year nuclear agreement with Saudi Arabia providing the kingdom a civilian nuclear program and potentially allowing uranium enrichment on Saudi territory,...

Read more

US Widens Iran Strikes to Tabriz on Day 11 — Both Sides Dismiss Diplomacy as Oil Hits $95 and War Costs Reach $37.5 Billion

by Team Lumida
5 days ago
Iran Tightens Its Grip on Hormuz Despite the Ceasefire — Charging Tolls and Limiting Traffic

The US expanded its bombing campaign to Tabriz in northwestern Iran on the 11th consecutive day of strikes, while both Washington and Tehran dismissed near-term diplomatic prospects —...

Read more

Trump Threatens 100% Tariff on Generic Drugs From 2028 — Putting 90% of US Prescriptions and India’s $10.5B Pharma Exports at Risk

by Team Lumida
5 days ago
Supreme Court Signals It Will Strike Down Trump’s Birthright Citizenship Order

President Trump announced a 100% tariff on imported generic drugs effective August 2028, escalating to 200% in August 2029, targeting the global supply chain that produces more than...

Read more

Iran Ballistic Missile Hit US Troop Housing at Jordan Base — Exposing Limits of American Missile Defense

by Team Lumida
5 days ago
Iran Tightens Its Grip on Hormuz Despite the Ceasefire — Charging Tolls and Limiting Traffic

An Iranian ballistic missile strike on Muwaffaq Salti Air Base in Jordan hit prefabricated housing units where US troops lived and slept, killing two soldiers from Army air...

Read more
Next Post
China’s Bold Economic Moves: What You Need to Know Now

China Pushes Trump to Ease Security Curbs in Exchange for Investment

A cell phone sitting on top of a wooden table

Terraformation’s Tree‑Subscription Service

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Dado Ruvic

Steno Research’s Bold Prediction: Ether’s Golden Age Ahead

September 20, 2024
selective focus photo of Bitcoin near monitor

Bitcoin and Nasdaq May Stabilize as Yen Bullish Positioning Looks Overstretched

March 11, 2025
China’s AI Startups Challenge Global Leaders Amid U.S. Trade Curbs

Jeremy Grantham Calls AI a Classic Bubble: Transformative Tech, Inflated Public-Market Pricing

January 19, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018